About US
Contact us
-
Deals this week: GE Ventures, Shanghai Fosun Pharma, Cambrooke TherapeuticsGE Venturesand Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks, Inc., which will expedite the treatment of cancer and other diseases by providing therapy producers2016/4/19
-
M&A this week: Advantis, Sequence Therapy, Madrigal Pharma, Synta PharmaAdvantis Corp.,has acquired a 25% stake in US-based pain management and physical therapy company Sequence Therapy, LLC, which sees an exponential growth in revenue, from the current $0.5m a year, with2016/4/19
-
Roche's atezo gets FDA fast track, BMS, Merck showdown comingWatch out,KeytrudaandOpdivo: Rochesnagged anotherFDApriority review for its cancer immunotherapy atezolizumab, this time in lung cancer. The Swiss drugmaker has big plans for the therapy, including an2016/4/18
-
Pfizer delay, alleged price gouging earns wrath of British watchdogIn case anyone thought it was just the U.S. where pharma has been accused of hiking prices, the U.K. has been quick to remind everyone it happens across the pond as well, after hitting Pfizer ($PFE) w2016/4/18
-
New study identifies fertility app as effective alternative to contraceptive pillNaturalCycles, a new fertility app, could be an effective hormone-free alternative to contraceptive pill to prevent and monitor pregnancies, a recent study has revealed. Developed by Dr Elina Berglun2016/4/15
-
Nordic Nanovector and PSI to develop new ARCs to treat single cell leukaemiaAnti-cancer therapeutics developer Nordic Nanovector has entered into a collaboration with Paul Scherrer Institute (PSI) in Switzerland, to develop new antibody radionuclide conjugates (ARCs) for trea2016/4/15
-
US FDA approves Venclexta tablets to treat chronic lymphocytic leukaemiaThe US Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) to treat chronic lymphocytic leukaemia (CLL) in patients with a specific chromosomal abnormality. Designed to2016/4/14
-
Researchers suspect link between Zika virus and acute disseminated encephalomyelitisA new report presented at the American Academy of Neurology's 68th annual meeting suggests that the Zika virus may be responsible for the cause of acute disseminated encephalomyelitis (ADEM), an autoi2016/4/14
-
Valeant wins new 10-K deadline from creditors, but gives up dealmaking freedom in returnValeant Pharmaceuticals ($VRX) snagged creditor approval to extend its annual report filing deadline into May in return for some concessions on its debt terms. The company had been in danger of defaul2016/4/13
-
Drug industry lashes out at Massachusetts drug price transparency effortThe Boston and Cambridge area may be one of the top biotech research hubs in the world. But that hasn't buffered it from the anger of some state lawmakers over the costs of some drugs they say are eat2016/4/13